Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors (Q34372994)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors |
scientific article |
Statements
1 reference
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors (English)
1 reference
Devalingam Mahalingam
1 reference
Monica Mita
1 reference
John Sarantopoulos
1 reference
Leslie Wood
1 reference
Ravi K Amaravadi
1 reference
Lisa E Davis
1 reference
Alain C Mita
1 reference
Tyler J Curiel
1 reference
Claudia M Espitia
1 reference
Steffan T Nawrocki
1 reference
Francis J Giles
1 reference
Jennifer S Carew
1 reference
20 May 2014
1 reference
1 reference
10
1 reference
8
1 reference
1403-1414
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference